Lipase catalysed kinetic resolution of racemic 1,2-diols containing a chiral quaternary center
Abstract
Optically active 1,2-diols are valuable buildings blocks in organic synthesis. In the present paper, a set of racemic 1,2-diols with an ester functional group are prepared, starting from -ketoesters in a three-step procedure with moderate yields. The racemic 1,2-diols, containing a chiral quaternary center in their structure, are subjected to selective acylation in order to perform their kinetic resolution catalysed by a set of commercially available lipases. Under optimized reaction conditions, good conversions and enantioselectivities are achieved by using the lipase PSL-C from Pseudomonas cepacia in tert-butyl methyl ether. This biocatalyst could be reused up to five times without losing its properties.
Full text
molecules Article Lipase Catalysed Kinetic Resolution of Racemic 1,2-Diols Containing a Chiral Quaternary Center Gonzalo de Gonzalo ID Departamento de Química Orgánica, Universidad de Sevilla, c/Profesor García González 1, 41012 Sevilla, Spain; [email protected]; Tel.: +34-954559997 Received: 25 May 2018; Accepted: 27 June 2018; Published: 29 June 2018 Abstract: Optically active 1,2-diols are valuable buildings blocks in organic synthesis. In the present paper, a set of racemic 1,2-diols with an ester functional group are prepared, starting from α -ketoesters in a three-step procedure with moderate yields. The racemic 1,2-diols, containing a chiral quaternary center in their structure, are subjected to selective acylation in order to perform their kinetic resolution catalysed by a set of commercially available lipases. Under optimized reaction conditions, good conversions and enantioselectivities are achieved by using the lipase PSL-C from Pseudomonas cepacia in tert-butyl methyl ether. This biocatalyst could be reused up to five times without losing its properties. Keywords: biocatalysis; lipases; kinetic resolution; 1,2-diols 1. Introduction Optically active 1,2-diols are valuable compounds as they can be transformed into several interesting molecules [ 1 – 3 ]. Due to their importance as building blocks in organic synthesis, a number of synthetic methodologies have been developed for their preparation [ 4 , 5 ]. One of the most widely applied methods is Sharpless asymmetric dihydroxylation, which involves the oxidation of alkenes to form 1,2-diols in presence of chiral catalysts [ 6 , 7 ]. This methodology suffers some limitations including the relatively low activity and selectivity of the aromatic compounds and the substrate scope. For these reasons, different alternatives have been investigated. The use of biologically active systems as catalysts in organic reactions, including whole cells, cells free extracts, or purified enzymes, has emerged as a powerful tool for the preparation of high added value compounds under mild and environmentally friendly conditions [8–11]. The enzymes that have been used to catalyse the formation of chiral 1,2-diols belong to the oxidoreductases (alcohol dehydrogenases and dioxygenases) [ 12 , 13 ], and the hydrolases, including epoxide hydrolases [ 14 , 15 ] and lipases. This last group of enzymes (EC 3.1.1.3) have demonstrated their synthetic applicability, being the most used type of enzymes in industrial chemistry [ 16 – 18 ]. Lipases are widely available, have broad substrate acceptance and are able to catalyse reactions not only in aqueous mediums, but also in organic solvents, which expands their synthetic repertoire. In addition, lipases usually display a high degree of chemo-, regio- and/or enantioselectivity in the processes that they catalyse. Lipases have been used to prepare optically active 1,2-diols catalysing the kinetic resolution of racemic mixtures in acylation reactions, thus leading to chiral diols and esters that can be converted back to the starting diols via hydrolysis [ 19 – 22 ]. In 2000, the kinetic resolution of racemic ethyl 2-benzyl-2,3-dihydroxypropanoate was described, a 1,2-diol containing an ester moiety precursor in the synthesis of (R)-etomoxir, which is a powerful hypoglucemic reagent [ 23 ]. After testing different biocatalysts, the lipase PS from Amano was found to catalyse the formation of (R)-1,2-diol and (S)-acetate with high selectivity and activity. Given this result, we decided to synthesise a set of Molecules 2018,23, 1585; doi:10.3390/molecules23071585 www.mdpi.com/journal/molecules
Molecules 2018,23, 1585 2 of 10 functionalised 1,2-diols with an ester group and perform their kinetic resolution in the presence of different lipases, with the aim of obtaining these valuable optically active compounds. 2. Results and Discussion 2.1. Preparation of the Racemic 1,2-Diols (±)-1–6d The racemic 1,2-diols were prepared in a three-step procedure starting from the corresponding α -ketoesters 1 – 6a , as indicated in Table 1. These compounds were treated with N-tert-butyl formaldehyde hydrazone in toluene at room temperature to yield the racemic azocompounds ( ± )- 1 – 6b with high yields (75–92%) after 24 h. For almost all the ketoesters, the reaction occurred in the absence of any catalyst, but for ethyl benzoylformate ( 1a ), the addition was accelerated in the presence of the Schreiner’s thiourea ( I ) at 10 mol%. The resulting azocompounds are valuable synthons that can be transformed in different compounds [ 24 – 26 ]. Their hydrolysis in a biphasic system Et 2 O/HCl (aq) yielded the corresponding hydroxyaldehydes ( ± )- 1 – 6c after four hours via a tautomerization and hydrolysis process. Debt to their instability were directly reduced without purification to the racemic 1,2-diols ( ± )- 1 – 6d by treatment with a mild reductant as tetrabutylammonium borohydride (NBu 4 BH 4 ) in CH 2 Cl 2 at room temperature over two hours. Depending on the substrate structure, the 1,2-diols were obtained with yields from 41 to 57%. Attempts to improve these yields by modifying certain reaction parameters as the hydrolysis conditions or the reducing agent were unsuccessful. Table 1. Synthesis of racemic 1,2-diols ( ± )- 1 – 6d in a three-step procedure starting from the commercially available α-ketoesters 1–6a. Molecules2018,23,xFORPEERREVIEW 2of10 functionalised1,2‐diolswithanestergroupandperformtheirkineticresolutioninthepresenceof differentlipases,withtheaimofobtainingthesevaluableopticallyactivecompounds. 2.ResultsandDiscussion 2.1.PreparationoftheRacemic1,2‐Diols(±)‐1–6d Theracemic1,2‐diolswerepreparedinathree‐stepprocedurestartingfromthecorresponding α‐ketoesters1–6a,asindicatedinTable1.ThesecompoundsweretreatedwithN‐tert‐butyl formaldehydehydrazoneintolueneatroomtemperaturetoyieldtheracemicazocompounds(±)‐1– 6bwithhighyields(75–92%)after24h.Foralmostalltheketoesters,thereactionoccurredinthe absenceofanycatalyst,butforethylbenzoylformate(1a),theadditionwasacceleratedinthe presenceoftheSchreiner’sthiourea(I)at10mol%.Theresultingazocompoundsarevaluable synthonsthatcanbetransformedindifferentcompounds[24–26].Theirhydrolysisinabiphasic systemEt2O/HCl(aq)yieldedthecorrespondinghydroxyaldehydes(±)‐1–6cafterfourhoursviaa tautomerizationandhydrolysisprocess.Debttotheirinstabilityweredirectlyreducedwithout purificationtotheracemic1,2‐diols(±)‐1–6dbytreatmentwithamildreductantas tetrabutylammoniumborohydride(NBu4BH4)inCH2Cl2atroomtemperatureovertwohours. Dependingonthesubstratestructure,the1,2‐diolswereobtainedwithyieldsfrom41to57%. Attemptstoimprovetheseyieldsbymodifyingcertainreactionparametersasthehydrolysis conditionsorthereducingagentwereunsuccessful. Table1.Synthesisofracemic1,2‐diols(±)‐1–6dinathree‐stepprocedurestartingfromthe commerciallyavailableα‐ketoesters1–6a. EntryR1R2nYield(±)‐1–6baYield(±)‐1–6da 1PhEt0(±)‐1b,b87(±)‐1d,47 2PhMe0(±)‐2b,80(±)‐2d,49 34‐CN‐PhEt0(±)‐3b,92(±)‐3d,55 44‐OMe‐PhEt0(±)‐4b,85(±)‐4d,45 52‐ThiophenylEt0(±)‐5b,90(±)‐5d,41 6HEt2(±)‐6b,85(±)‐6d,57 aForreactionconditions,seeMaterialsandMethods.bReactionperformedwith10mol%ofcatalystI. 2.2.KineticResolutionofRacemicDiols(±)‐1–6d Oncetheracemic1,2‐diolsweresynthesized,theirkineticresolutionwasperformed.Ourinitial studieswereperformedusingracemicethyl2,3‐dihydroxy‐2‐phenylpropanoate(±)‐1dasthemodel substrate.Theselectiveacetylationofthis1,2‐diol(0.15M)intolueneat30°Cwasperformedin presenceof3.0equivalentsofvinylacetatetoensureanirreversibleacylationprocess.Theeffectsof Entry R1R2n Yield (±)-1–6b aYield (±)-1–6d a 1 Ph Et 0 (±)-1b,b87 (±)-1d, 47 2 Ph Me 0 (±)-2b, 80 (±)-2d, 49 3 4-CN-Ph Et 0 (±)-3b, 92 (±)-3d, 55 4 4-OMe-Ph Et 0 (±)-4b, 85 (±)-4d, 45 5 2-Thiophenyl Et 0 (±)-5b, 90 (±)-5d, 41 6 H Et 2 (±)-6b, 85 (±)-6d, 57 aFor reaction conditions, see Materials and Methods. bReaction performed with 10 mol% of catalyst I. 2.2. Kinetic Resolution of Racemic Diols (±)-1–6d Once the racemic 1,2-diols were synthesized, their kinetic resolution was performed. Our initial studies were performed using racemic ethyl 2,3-dihydroxy-2-phenylpropanoate ( ± )- 1d as the model substrate. The selective acetylation of this 1,2-diol (0.15 M) in toluene at 30 ◦ C was performed in
Molecules 2018,23, 1585 3 of 10 presence of 3.0 equivalents of vinyl acetate to ensure an irreversible acylation process. The effects of different biocatalysts were analysed by screening several commercially available lipases, as indicated in Table 2. For all the biocatalysts tested, the (S)-enantiomer of the 1,2-diol was acetylated, yielding (S)- 1e , whereas the (R)-1,2-diol remained unaltered. The use of immobilized Candida antarctica lipase B (CalB) resulted in a reaction without selectivity (entry 1), achieving a 23% conversion after four hours. When the reaction was catalysed by its isozyme A (entry 2), a more selective process was observed (enantioselectivity, E= 12), demonstrating acylation slower than with CalB. As shown in entry 3, Pseudomonas cepacia lipase (PSL-C) seems to be the most suitable biocatalyst for this reaction, as a moderate Evalue was obtained in a process with a 32% conversion after 20 h, achieving (S)- 1d with 86% ee. The use of lipases from Pseudomonas fluorescens (PSF), Burkholderia sp. (BSL), Rhizopus oryzae, and Aspergillus oryzae led to very low enantioselectivities (E< 10, entries 4–7), with conversions varying from 41% after 20 h with PSF, to 16% with the same duration using the lipase from Aspergillus oryzae. The kinetic resolution catalysed by porcine pancreatic lipase (PPL) in toluene afforded a selectivity value of 13, and a conversion close to 50% after 24 h, as shown in entry 8. The opposite lipase from Mucor miehei was not a suitable biocatalyst for this reaction, as only a 13% of (S)- 1e was obtained after 24 h in a very low selective resolution (entry 9). Table 2. Lipase-catalysed acylation of rac-ethyl 2,3-dihydroxy-2-phenylpropanoate ( 1d ) at different reaction conditions. Molecules2018,23,xFORPEERREVIEW 3of10 differentbiocatalystswereanalysedbyscreeningseveralcommerciallyavailablelipases,as indicatedinTable2.Forallthebiocatalyststested,the(S)‐enantiomerofthe1,2‐diolwasacetylated, yielding(S)‐1e,whereasthe(R)‐1,2‐diolremainedunaltered.TheuseofimmobilizedCandida antarcticalipaseB(CalB)resultedinareactionwithoutselectivity(entry1),achievinga23% conversionafterfourhours.WhenthereactionwascatalysedbyitsisozymeA(entry2),amore selectiveprocesswasobserved(enantioselectivity,E=12),demonstratingacylationslowerthanwith CalB.Asshowninentry3,Pseudomonascepacialipase(PSL‐C)seemstobethemostsuitable biocatalystforthisreaction,asamoderateEvaluewasobtainedinaprocesswitha32%conversion after20h,achieving(S)‐1dwith86%ee.TheuseoflipasesfromPseudomonasfluorescens(PSF), Burkholderiasp.(BSL),Rhizopusoryzae,andAspergillusoryzaeledtoverylowenantioselectivities(E< 10,entries4–7),withconversionsvaryingfrom41%after20hwithPSF,to16%withthesame durationusingthelipasefromAspergillusoryzae.Thekineticresolutioncatalysedbyporcine pancreaticlipase(PPL)intolueneaffordedaselectivityvalueof13,andaconversioncloseto50% after24h,asshowninentry8.TheoppositelipasefromMucormieheiwasnotasuitablebiocatalyst forthisreaction,asonlya13%of(S)‐1ewasobtainedafter24hinaverylowselectiveresolution (entry9). Table2.Lipase‐catalysedacylationofrac‐ethyl2,3‐dihydroxy‐2‐phenylpropanoate(1d)atdifferent reactionconditions. EntryLipaseSolventT(°C)t(h)c(%)aee1d(%)bee1e(%)cEd 1CalBToluene3042311372 2CalAToluene301232377712 3PSL‐CToluene302032408620 4PSFToluene30204135504 5BSLToluene30203842698 6R.oryzaeToluene30202322759 7A.oryzaeToluene30201611574 8PPLToluene302448677313 9M.mieheiToluene20241312789 10PSL‐CTBME301242629141 11CalATBME30641547917 12PPLTBME301238507713 13PSL‐C1,4‐Dioxane302023258617 14PSL‐CTHF3020668715 15PSL‐CDIPE301245678322 16PSL‐CTBME152443679143 17PSL‐CeTBME302436529137 18PSL‐CfTBME304834479134 aConversion,c=ees/(ees+eep).bEnantiomericexcessesweredeterminedbyhighperformanceliquid chromatography(HPLC)afteracetylationinpresenceofaceticanhydrideinpyridine.cDetermined byHPLC.dEnantioselectivity(E)value,E=ln[1−c(1+eep)]/ln[1−c(1−eep)].eReactionperformed withisopropenylacetateasacyldonor.fReactionperformedwithethylacetateasacyldonor. AfterselectingPSL‐Casthebestbiocatalystfortheacetylationofracemic1d,weanalysedother parametersthatcanaffecttheactivityandselectivityofthebiocatalyst.Thus,differentorganic solventsweretestedintheacylationreaction.Asshowninentry10,tert‐butylmethylether(TBME) wasthebestsolventforthisprocess,asagoodselectivityvaluecouldbeachieved(E=41)ina reactionmuchfasterthanintoluene(34%conversionaftereighthourswith91%eefor1e).This Entry Lipase Solvent T (◦C) t (h) c(%) aee 1d (%) bee 1e (%) cEd 1 CalB Toluene 30 4 23 11 37 2 2 CalA Toluene 30 12 32 37 77 12 3 PSL-C Toluene 30 20 32 40 86 20 4 PSF Toluene 30 20 41 35 50 4 5 BSL Toluene 30 20 38 42 69 8 6R. oryzae Toluene 30 20 23 22 75 9 7A. oryzae Toluene 30 20 16 11 57 4 8 PPL Toluene 30 24 48 67 73 13 9M. miehei Toluene 20 24 13 12 78 9 10 PSL-C TBME 30 12 42 62 91 41 11 CalA TBME 30 6 41 54 79 17 12 PPL TBME 30 12 38 50 77 13 13 PSL-C 1,4-Dioxane 30 20 23 25 86 17 14 PSL-C THF 30 20 6 6 87 15 15 PSL-C DIPE 30 12 45 67 83 22 16 PSL-C TBME 15 24 43 67 91 43 17 PSL-C eTBME 30 24 36 52 91 37 18 PSL-C fTBME 30 48 34 47 91 34 a Conversion, c=ee s /(ee s +ee p ). b Enantiomeric excesses were determined by high performance liquid chromatography (HPLC) after acetylation in presence of acetic anhydride in pyridine. c Determined by HPLC. d Enantioselectivity (E) value, E= ln[1 − c(1 + ee p )]/ln [1 − c(1 − ee p )]. e Reaction performed with isopropenyl acetate as acyl donor. fReaction performed with ethyl acetate as acyl donor. After selecting PSL-C as the best biocatalyst for the acetylation of racemic 1d , we analysed other parameters that can affect the activity and selectivity of the biocatalyst. Thus, different organic solvents were tested in the acylation reaction. As shown in entry 10, tert-butyl methyl ether (TBME) was the best solvent for this process, as a good selectivity value could be achieved (E= 41) in a reaction much faster than in toluene (34% conversion after eight hours with 91% ee for 1e ). This solvent was also tested in the CalA-catalysed acylation, promoting an increase in both the enzyme activity and selectivity (entry
Molecules 2018,23, 1585 4 of 10 11). However, the Evalue remained low. The reaction catalysed by PPL in TBME afforded the chiral acetate (S)- 1e with 77% ee in a process with a 38% conversion after 12 h (entry 12). Other solvents analysed in the acetylation catalysed by PSL-C, such as 1,4-dioxane or THF, led to slower resolutions and especially for the latter, whereas the enantioselectivities were around 15. The use of diisopropyl ether (DIPE) afforded (R)- 1d with 67% ee and (S)- 1e with 83% ee in a process with a 45% conversion after 12 h (entry 15). The effect of temperature was also analysed in this kinetic resolution, performing the PSL-C-catalysed reaction of ( ± )- 1d at 15 ◦ C, as shown in entry 16. Lowering the temperature had no effect on the enzyme selectivity, whereas, as expected, the enzyme activity dropped (c= 25% after 12 h). The use of a less reactive acyl donor, such as isopropenyl acetate (entry 17), led to a similar selectivity. Chiral acetate (S)- 1e was obtained with a 36% conversion and 91% ee after 16 h. When ethyl acetate was used as acyl donor (entry 17), a slower kinetic resolution was achieved, as 48 h were required to obtain a 34% yield of (S)-1e with 91% ee (entry 18). The recycling of the PSL-C was studied in the selective acetylation of ( ± )- 1e with vinyl acetate in TBME at 30 ◦ C. After 20 h, the biocatalyst was filtered, washed with TBME, and used again in a new reaction cycle. As shown in Figure 1, this biocatalyst could perform the selective acylation of the racemic diol for five cycles while maintaining its activity and selectivity. For the sixth reaction, a significant drop in the enantioselectivity of the process was observed (E=27). For the seventh reaction, this drop was accompanied by an appreciable loss in enzymatic conversion. Molecules2018,23,xFORPEERREVIEW 4of10 solventwasalsotestedintheCalA‐catalysedacylation,promotinganincreaseinboththeenzyme activityandselectivity(entry11).However,theEvalueremainedlow.Thereactioncatalysedby PPLinTBMEaffordedthechiralacetate(S)‐1ewith77%eeinaprocesswitha38%conversionafter 12h(entry12).OthersolventsanalysedintheacetylationcatalysedbyPSL‐C,suchas1,4‐dioxaneor THF,ledtoslowerresolutionsandespeciallyforthelatter,whereastheenantioselectivitieswere around15.Theuseofdiisopropylether(DIPE)afforded(R)‐1dwith67%eeand(S)‐1ewith83%eein aprocesswitha45%conversionafter12h(entry15). Theeffectoftemperaturewasalsoanalysedinthiskineticresolution,performingthe PSL‐C‐catalysedreactionof(±)‐1dat15°C,asshowninentry16.Loweringthetemperaturehadno effectontheenzymeselectivity,whereas,asexpected,theenzymeactivitydropped(c=25%after12 h).Theuseofalessreactiveacyldonor,suchasisopropenylacetate(entry17),ledtoasimilar selectivity.Chiralacetate(S)‐1ewasobtainedwitha36%conversionand91%eeafter16h.When ethylacetatewasusedasacyldonor(entry17),aslowerkineticresolutionwasachieved,as48h wererequiredtoobtaina34%yieldof(S)‐1ewith91%ee(entry18). TherecyclingofthePSL‐Cwasstudiedintheselectiveacetylationof(±)‐1ewithvinylacetatein TBMEat30°C.After20h,thebiocatalystwasfiltered,washedwithTBME,andusedagaininanew reactioncycle.AsshowninFigure1,thisbiocatalystcouldperformtheselectiveacylationofthe racemicdiolforfivecycleswhilemaintainingitsactivityandselectivity.Forthesixthreaction,a significantdropintheenantioselectivityoftheprocesswasobserved(E=27).Fortheseventh reaction,thisdropwasaccompaniedbyanappreciablelossinenzymaticconversion. Figure1.EffectofthePSL‐Crecyclingontheconversion(blueline)andontheenantioselectivity(red bar)inthecatalysedkineticresolutionof(±)‐1dintert‐butylmethylether(TBME)at30°Cusingvinyl acetateasheacyldonor. Aftertheoptimizedconditionsweresetupforthekineticresolutionofracemicethyl 2,3‐dihydroxy‐2‐phenylpropanoate,usingPSL‐CandCalAinTBMEat30°Candvinylacetateas acyldonor,thescopeofthereactionusingdifferentaromatic1,2‐diolswasstudied(Table3).Forall thesubstrates,(S)‐acetates2–6eweretheobtainedproducts.TheuseofPSL‐Cledtohigher enatioselectivitiesinallthearomaticandtheheteroaromaticsubstrates(2–5a),whereasCalA showedhigheractivity.Thus,theenzymaticacylationofracemicmethyl 2,3‐dihydroxy‐2‐phenylpropanoate(2d)catalysedbyPSL‐Coccurredwiththesameselectivityasfor theethylanalogue1d(E=42,entry1)andwithahigherconversion,achievinga41%conversion after12h.WhentheacylationwascatalysedbyCalA(entry2)(S)‐2ewasobtainedwith80%eeanda 42%conversionaftereighthours(E=16).Thep‐cyanoderivative(±)‐3cwasagoodsubstrateforboth catalysts(entries3and4).WhenusingPSL‐C,a44%of(S)‐3ewith90%eewasobtainedafter12h,in aresolutionwithagoodenantioselectivityvalue(E=40),whereastheresolutioncatalysedbyCalA ledtoa47%conversionaftereighthoursandagoodselectivity(E=30).Thepresenceofan Figure 1. Effect of the PSL-C recycling on the conversion (blue line) and on the enantioselectivity (red bar) in the catalysed kinetic resolution of ( ± )- 1d in tert-butyl methyl ether (TBME) at 30 ◦ C using vinyl acetate as he acyl donor. After the optimized conditions were set up for the kinetic resolution of racemic ethyl 2,3-dihydroxy-2-phenylpropanoate, using PSL-C and CalA in TBME at 30 ◦ C and vinyl acetate as acyl donor, the scope of the reaction using different aromatic 1,2-diols was studied (Table 3). For all the substrates, (S)-acetates 2 – 6e were the obtained products. The use of PSL-C led to higher enatioselectivities in all the aromatic and the heteroaromatic substrates ( 2 – 5a ), whereas CalA showed higher activity. Thus, the enzymatic acylation of racemic methyl 2,3-dihydroxy-2-phenylpropanoate ( 2d ) catalysed by PSL-C occurred with the same selectivity as for the ethyl analogue 1d (E= 42, entry 1) and with a higher conversion, achieving a 41% conversion after 12 h. When the acylation was catalysed by CalA (entry 2) (S)- 2e was obtained with 80% ee and a 42% conversion after eight hours (E= 16). The p-cyano derivative ( ± )- 3c was a good substrate for both catalysts (entries 3 and 4). When using PSL-C, a 44% of (S)- 3e with 90% ee was obtained after 12 h, in a resolution with a good enantioselectivity value (E= 40), whereas the resolution catalysed by CalA led to a 47% conversion
Molecules 2018,23, 1585 5 of 10 after eight hours and a good selectivity (E= 30). The presence of an electron-donating group in the aromatic ring of the diol seemed to have a negative effect on both the activity (41% of (S)- 4e after 24 h) and the selectivity (E= 32) of PSL-C (entry 3). This substrate was tested with CalA, but a low selectivity was observed (E= 11), in a kinetic resolution with a 36% conversion after 16 h, as shown in entry 6. A heteroaromatic 1,2-diol as ( ± )- 5d was successfully resolved by PSL-C in MTBE. After 24 h, a 45% of (S)- 5e with 88% ee was achieved in a process with good selectivity, as shown in entry 7. The use of CalA led to a 38% conversion after 16 h and moderate selectivity (E= 17, entry 8). Table 3. PSL-C catalysed kinetic resolution of racemic diols 2–6d in tert-butyl methyl ether (TBME) at 30 ◦C using vinyl acetate as the acyl donor. Molecules2018,23,xFORPEERREVIEW 5of10 electron‐donatinggroupinthearomaticringofthediolseemedtohaveanegativeeffectonboththe activity(41%of(S)‐4eafter24h)andtheselectivity(E=32)ofPSL‐C(entry3).Thissubstratewas testedwithCalA,butalowselectivitywasobserved(E=11),inakineticresolutionwitha36% conversionafter16h,asshowninentry6.Aheteroaromatic1,2‐diolas(±)‐5dwassuccessfully resolvedbyPSL‐CinMTBE.After24h,a45%of(S)‐5ewith88%eewasachievedinaprocesswith goodselectivity,asshowninentry7.TheuseofCalAledtoa38%conversionafter16hand moderateselectivity(E=17,entry8). Table3.PSL‐Ccatalysedkineticresolutionofracemicdiols2‐6dintert‐butylmethylether(TBME)at 30°Cusingvinylacetateastheacyldonor. EntrySubstrateLipaseR1R2nt(h)c(%)aee2‐6d(%)bee2‐6e(%)cEd 1(±)‐2dPSL‐CPhMe01241639142 2(±)‐2dCalAPhMe0842598016 3(±)‐3dPSL‐C4‐CN‐PhEt01244719040 4(±)‐3dCalA4‐CN‐PhEt0847778630 5(±)‐4dPSL‐C4‐OMe‐PhEt02441628932 6(±)‐4dCalA4‐OMe‐PhEt01636427211 7(±)‐5dPSL‐C2‐ThiophenylEt02445738833 8(±)‐5dCalA2‐ThiophenylEt01638478317 9(±)‐6dPSL‐CPhEt224550627 10(±)‐6dCalAPhEt2617178212 11e(±)‐6dPSL‐CPhEt2615148010 12f(±)‐6dPSL‐CPhEt2417188616 aConversion,c=ees/(ees+eep).bEnantiomericexcessesweredeterminedbyHPLCafteracetylationin presenceofaceticanhydrideinpyridine.cDeterminedbyHPLC.dEnantioselectivity(E)value,E= ln[1−c(1+eep)]/ln[1−c(1−eep)].eReactioncarriedoutwithethylacetateasacyldonor.fReaction carriedoutat10°C. Regardingthealiphaticdiol(±)‐6d,inwhichthestereogeniccenterpresentsanaliphatic substituent,theenzymaticacylationinTBMEat30°CusingPSL‐Caffordedaverylow enantioselectivityvalue(E=7)inaveryfastresolution,achievinga45%of(S)‐6eafter2h.Inviewof thisresult,theisozymeAfromCandidaantarcticawastested,leadingtoaslower(c=17%after6h), butslightlymoreselectiveprocess(E=12)thanwithPSL‐C(seeentry10).Inordertoimprovethe reactionselectivity,thePSL‐C‐catalysedresolutionswerecarriedoutusingethylacetateasaless reactiveacyldonor.After6h,a15%of(S)‐6ewasobtainedinaprocesswithalowenantioselectivity (E=10).Finally,thekineticresolutioninpresenceofvinylacetatewasconductedat10°C.After4h, a17%ofdiol6dwasconvertedintotheacetate(S)‐6ewith86%ee,buttheEvaluewasonlyincreased to16(entry12),indicatingthatthissubstratewasnotappropriateforthebiocatalysedacylation. 3.MaterialsandMethods Unlessotherwisenoted,analyticalgradesolventsandcommerciallyavailablereagentswere usedwithoutfurtherpurification.Formaldehydetert‐butylhydrazone[27]andorganocatalystI[28] weresynthesizedaccordingtotheliterature.Racemicazocompounds(±)‐1–6b[24,26]and1,2‐diols (±)‐1dand(±)‐4,5d[29]exhibitedthesamephysicalandspectralpropertiesasdescribedinthe bibliographyandthenuclearmagneticresonance(NMR)dataofthe1,2‐diolsareshowninthe SupplementaryInformation.PseudomonascepacialipasePSL‐C(1638U/g)andlipasesfrom Pseudomonasfluorescens(≥160U/mg),Rhizopusoryzae(≥30U/mg),Aspergillusoryzae(ca.50U/mg), Burkholderiasp.(≥160U/mg),porcinepancreatic(≥20,000U/mg),andMucormiehei(≥4000U/mg) Entry Substrate Lipase R1R2n t (h) c(%) aee 2-6d (%) bee 2-6e (%) cEd 1 (±)-2d PSL-C Ph Me 0 12 41 63 91 42 2 (±)-2d CalA Ph Me 0 8 42 59 80 16 3 (±)-3d PSL-C 4-CN-Ph Et 0 12 44 71 90 40 4 (±)-3d CalA 4-CN-Ph Et 0 8 47 77 86 30 5 (±)-4d PSL-C 4-OMe-Ph Et 0 24 41 62 89 32 6 (±)-4d CalA 4-OMe-Ph Et 0 16 36 42 72 11 7 (±)-5d PSL-C 2-Thiophenyl Et 0 24 45 73 88 33 8 (±)-5d CalA 2-Thiophenyl Et 0 16 38 47 83 17 9 (±)-6d PSL-C Ph Et 2 2 45 50 62 7 10 (±)-6d CalA Ph Et 2 6 17 17 82 12 11 e(±)-6d PSL-C Ph Et 2 6 15 14 80 10 12 f(±)-6d PSL-C Ph Et 2 4 17 18 86 16 a Conversion, c=ee s /(ee s +ee p ). b Enantiomeric excesses were determined by HPLC after acetylation in presence of acetic anhydride in pyridine. c Determined by HPLC. d Enantioselectivity (E) value, E= ln[1 − c(1 + ee p )]/ln [1 − c(1 −eep)]. eReaction carried out with ethyl acetate as acyl donor. fReaction carried out at 10 ◦C. Regarding the aliphatic diol ( ± )- 6d , in which the stereogenic center presents an aliphatic substituent, the enzymatic acylation in TBME at 30 ◦ C using PSL-C afforded a very low enantioselectivity value (E= 7) in a very fast resolution, achieving a 45% of (S)- 6e after 2 h. In view of this result, the isozyme A from Candida antarctica was tested, leading to a slower (c= 17% after 6 h), but slightly more selective process (E= 12) than with PSL-C (see entry 10). In order to improve the reaction selectivity, the PSL-C-catalysed resolutions were carried out using ethyl acetate as a less reactive acyl donor. After 6 h, a 15% of (S)- 6e was obtained in a process with a low enantioselectivity (E= 10). Finally, the kinetic resolution in presence of vinyl acetate was conducted at 10 ◦ C. After 4 h, a 17% of diol 6d was converted into the acetate (S)- 6e with 86% ee, but the Evalue was only increased to 16 (entry 12), indicating that this substrate was not appropriate for the biocatalysed acylation. 3. Materials and Methods Unless otherwise noted, analytical grade solvents and commercially available reagents were used without further purification. Formaldehyde tert-butyl hydrazone [ 27 ] and organocatalyst I [ 28 ] were synthesized according to the literature. Racemic azocompounds ( ± )- 1 – 6b [ 24 , 26 ] and 1,2-diols ( ± )- 1d and ( ± )- 4,5d [29] exhibited the same physical and spectral properties as described in the bibliography and the nuclear magnetic resonance (NMR) data of the 1,2-diols are shown in the Supplementary Information. Pseudomonas cepacia lipase PSL-C (1638 U/g) and lipases from Pseudomonas fluorescens ( ≥ 160 U/mg), Rhizopus oryzae ( ≥ 30 U/mg), Aspergillus oryzae (ca. 50 U/mg), Burkholderia sp. (≥160 U/mg) , porcine pancreatic ( ≥ 20,000 U/mg), and Mucor miehei ( ≥ 4000 U/mg) were purchased from Sigma-Aldrich (Saint Louis, MO, USA). Candida antarctica lipase type B (CalB,
Molecules 2018,23, 1585 6 of 10 Novozyme 435, 7300 propyl laureate units per gram) was obtained from Novozymes (Bagsvaerd, Denmark). Candida antarctica lipase A (CalA) was obtained from Codexis (Redwood City, CA, USA). NMR spectra were recorded in CDCl 3 [ 1 H-NMR (300 MHz); 13 C-NMR (75.4 MHz)] with the solvent peak used as the internal reference (7.26 and 77.0 ppm for 1 H and 13 C, respectively). High-resolution mass spectrometry (HRMS) analyses were performed with an Orbitrap ELITE instrument (Waltham, ThermoFisher, MA, USA). Column chromatography was performed on silica gel (Merck Kieselgel 60, Kenilworth, NJ, USA). Analytical thin layer chromatography (TLC) was performed on aluminum backed plates (1.5 × 5.0 cm) precoated (0.25 mm) with silica gel (Merck, Silica Gel 60 F254, Kenilworth, NJ, USA). The compounds were visualized by exposure to UV light or by dipping the plates into solutions of KMnO 4 or vainilline stains followed by heating. HPLC analyses were performed on a Waters 2695 Instrument (Milford, MA, USA), equipped with a Waters 996 Photodiode Array Detector (Milford, MA, USA). To determine the enantiomeric excesses of diols (R)- 1 – 6d and acetates (S)- 1 – 6e , the following columns from Daicel (Tokyo, Japan) were employed: Chiralcel OD (25 × 0.46 cm) and Chiralpak AD-H (25 × 0.46 cm). The optical purity of the diols was measured after their derivatization to the corresponding acetates using acetic anhydride and pyridine in CH 2 Cl 2 . HPLC conditions and retention times are summarized in Table S1. The absolute configuration of the 1,2-diols (R)- 1 – 6d and the acetates (S)- 1 – 6e were established by comparison with the described values of the specific rotation for (R)-ethyl 2-benzyl-2,3-dihydroxypropanoate [23]. 3.1. General Procedure for the Synthesis of Racemic Azocompounds (±)-1–6b The corresponding α -ketoester 1 – 6a (5.0 mmol) was dissolved at room temperature in toluene (8.0 mL) and N-tert-butyl formaldehyde hydrazone (10 mmol) was added. For the ethyl benzoylformate, catalyst I (0.5 mmol, 10 mol%) was added prior to the hydrazone. Reactions were stirred at room temperature for 24 h until consumption of the starting material (TLC). The solvent was eliminated under reduced pressure and the obtained crudes were purified by column chromatography using toluene/EtOAc mixtures as the eluent in order to obtain the corresponding racemic azocompounds (±)-1–6b with yields between 80 and 92%. 3.2. General Preparation of the Racemic 1,2-diols (±)-1–6d Starting from Azocompounds (±)-1–6b The corresponding azocompound ( ± )- 1 – 6b (4.0 mmol) was dissolved in Et 2 O (35 mL), cooled to 0 ◦ C, and HCl 6.0 M (15 mL) was added. The reaction mixture was allowed to warm to room temperature and was stirred for 4 h, and then extracted with Et 2 O (2 × 15 mL) and CH 2 Cl 2 (2 × 15 mL). The organic layers were dried over Na 2 SO 4 and the solvent was eliminated in vacuo to create the crude α -hydroxyaldehydes ( ± )- 1 – 6c , which were further reduced without purification. Tetrabutylamonium borohydride (560 mg, 2.0 mmol) was added to a solution of the obtained aldehyde in CH 2 Cl 2 (15 mL) and the mixture was stirred at room temperature for 2 h. After evaporation of the organic solvent, the crude was purified by column chromatography using CH 2 Cl 2 /MeOH 97:3 as the eluent, yielding the racemic 1,2-diols (±)-1-6d (Figure 2). ( ± )-Ethyl 2,3-dihydroxy-2-phenylpropanoate, ( ± )- 1d : Yellow pale oil (395 mg, yield 47%). Spectroscopic data consistent with the literature [29]. ( ± )-Methyl 2,3-dihydroxy-2-phenylpropanoate, ( ± )- 2d : Yellow pale oil (384 mg, yield 49%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.53 (d, 2H, J= 8.0 Hz, H 7 ), 7.33–7.24 (m, 3H, H 6 and H 8 ), 4.18 (d, 1H, J= 10.8 Hz, H 3 ), 4.13 (bs, 1H, OH), 3.77 (s, 3H, H 1 ), 3.68 (d, 1H, J= 10.8 Hz, H 30 ), 2.80 (bs, 1H, OH). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 174.2 (C 2 ), 138.0 (C 5 ), 128.5 (C 7 ), 128.2 (C 6 ), 125.3 (C 8 ), 79.7 (C 4 ), 68.3 (C3), 53.5 (C1). HRMS: m/zcalcd. for C10H12NaO4(M + Na+): 219.02626; found: 219.02628. ( ± )-Ethyl 2-(4-cyanophenyl)-2,3-dihydroxypropanoate, ( ± )- 3d : Colorless oil (517 mg, yield 55%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.69 (d, 2H, J= 8.5 Hz, H 8 ), 7.59 (d, 2H, J= 8.5 Hz, H 7 ), 4.29–4.21 (m, 2H, H 2 ), 4.15 (d, 1H, J= 11.4 Hz, H 5 ), 4.07 (bs, 1H, OH), 3.66 (d, 1H, J= 11.4 Hz, H 50 ), 3.09 (bs, 1H, OH), 1.25 (t, 3H, J= 7.1 Hz, H 1 ). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 172.6 (C 3 ), 143.2 (C 6 ),
Molecules 2018,23, 1585 7 of 10 132.2 (C 8 ), 126.6 (C 7 ), 118.5 (C 10 ), 112.3 (C 9 ), 79.4 (C 4 ), 68.2 (C 5 ), 63.3 (C 2 ), 14.0 (C 1 ). HRMS: m/zcalcd. for C12H13NNaO4(M + Na+): 258.0739; found: 258.0737. ( ± )-Ethyl 2,3-dihydroxy-2-(4-methoxyphenyl)propanoate, ( ± )- 4d : Colorless oil (432 mg, yield 45%). Spectroscopic data consistent with the literature [29]. ( ± )-Ethyl 2,3-dihydroxy-2-(tiophen-2-yl)propanoate, ( ± )- 5d : White solid. m.p.: 76–78 ◦ C (354 mg, yield 41%). Spectroscopic data consistent with the literature [29]. ( ± )-Ethyl 2-hydroxy-2-hydroxymethyl-4-phenylbutanoate, ( ± )- 6d : Colorless oil (384 mg, yield 57%) 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.20–7.12 (m, 2H, H 10 ), 7.10–7.07 (m, 3H, H 9 and H 11 ), 4.15 (q, 2H, J= 7.0 Hz, H 2 ), 3.98 (s, OH), 3.73 (d, 1H, J= 11.2 Hz, H 5 ), 3.56 (d, 1H, J= 11.2 Hz, H 50 ), 2.91 (s, OH), 2.78–2.68 (m, 1H, H 6 ), 2.43–2.33 (m, 1H, H 60 ), 1.98–1.78 (m, 2H, H 7 ), 1.22 (t, 3H, J= 7.0 Hz, H 1 ). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 175.0 (C 3 ), 141.2 (C 8 ), 128.5 (C 10 ), 128.4 (C 9 ), 126.0 (C 11 ), 78.3 (C 4 ), 68.0 (C 5 ), 62.4 (C 2 ), 36.6 (C 6 ), 29.5 (C 7 ), 14.2 (C 1 ). HRMS: m/zcalcd. for C 13 H 18 NaO 4 (M + Na + ): 261.1102; found: 261.1097. Molecules2018,23,xFORPEERREVIEW 7of10 OH),1.25(t,3H,J=7.1Hz,H1).13C‐NMR(75.4MHz,CDCl3):δ(ppm)172.6(C3),143.2(C6),132.2(C8), 126.6(C7),118.5(C10),112.3(C9),79.4(C4),68.2(C5),63.3(C2),14.0(C1).HRMS:m/zcalcd.for C12H13NNaO4(M+Na+):258.0739;found:258.0737. (±)‐Ethyl2,3‐dihydroxy‐2‐(4‐methoxyphenyl)propanoate,(±)‐4d:Colorlessoil(432mg,yield45%). Spectroscopicdataconsistentwiththeliterature[29]. (±)‐Ethyl2,3‐dihydroxy‐2‐(tiophen‐2‐yl)propanoate,(±)‐5d:Whitesolid.m.p.:76–78°C(354mg, yield41%).Spectroscopicdataconsistentwiththeliterature[29]. (±)‐Ethyl2‐hydroxy‐2‐hydroxymethyl‐4‐phenylbutanoate,(±)‐6d:Colorlessoil(384mg,yield57%) 1H‐NMR(300MHz,CDCl3):δ(ppm)7.20–7.12(m,2H,H10),7.10–7.07(m,3H,H9andH11),4.15(q, 2H,J=7.0Hz,H2),3.98(s,OH),3.73(d,1H,J=11.2Hz,H5),3.56(d,1H,J=11.2Hz,H5′),2.91(s,OH), 2.78–2.68(m,1H,H6),2.43–2.33(m,1H,H6′),1.98–1.78(m,2H,H7),1.22(t,3H,J=7.0Hz,H1). 13C‐NMR(75.4MHz,CDCl3):δ(ppm)175.0(C3),141.2(C8),128.5(C10),128.4(C9),126.0(C11),78.3 (C4),68.0(C5),62.4(C2),36.6(C6),29.5(C7),14.2(C1).HRMS:m/zcalcd.forC13H18NaO4(M+Na+): 261.1102;found:261.1097. Figure2.StructureandNMRassignationofthesynthesizedracemic1,2‐diols(±)‐2,3dand6d. 3.3.GeneralSynthesisoftheRacemicAcetates(±)‐1–6e Toasolutionofthecorrespondingracemic1,2‐diol(±)‐1‐6d(0.2mmol)inCH2Cl2(2.0mL), pyridine(18μL,0.22mmol)andaceticanhydride(20μL,0.22mmol)wereaddedatroom temperature.Thereactionwasstirreduntildisappearanceofthestartingmaterial(TLCusing hexane/EtOAc7:3astheeluent).ThecrudereactionwaswashedwithHCl1.0N(2×2.0mL),dried withNa2SO4,andthesolventwasremovedunderreducedpressuretoyieldthecorresponding racemicacetates(±)‐1–6e,whichwereobtainedafterpurificationbycolumnchromatographyusing n‐hexane/EtOAc7:3aseluent(Figure3). (±)‐Ethyl3‐acetoxy‐2‐hydroxy‐2‐phenylpropanoate,(±)‐1e:Colorlessoil(45.8mg,yield91%). 1H‐NMR(300MHz,CDCl3):δ(ppm)7.57–7.54(m,2H,H10),7.31–7.27(m,3H,H9andH11),4.68–4.64 (d,1H,J=11.3Hz,H5),4.30–4.15(m,3H,H2andH5′),3.84(bs,1H,OH),2.00(s,3H,H7),1.22(t,3H,J= 7.1Hz,H1);13C‐NMR(75.4MHz,CDCl3):δ(ppm)172.8(C6)170.6(C3),137.6(C8),129.3(C10),128.5 (C9),125.6(C11),79.2(C4),68.8(C2),62.9(C5),20.7(C7),14.1(C1).HRMS:m/zcalcd.forC13H16NaO5(M +Na+):275.0892;found:275.0890. (±)‐Methyl3‐acetoxy‐2‐hydroxy‐2‐phenylpropanoate,(±)‐2e:Colorlessoil(44.2mg,yield93%). 1H‐NMR(300MHz,CDCl3):δ(ppm)δ(ppm)7.55(d,2H,J=8.2Hz,H9),7.31–7.27(m,3H,H8and H10),4.64(d,1H,J=11.2Hz,H4),4.31(d,1H,J=11.2Hz,H4′),3.77(s,3H,H1),2.54(bs,1H,OH),2.01 (s,3H,H6).13C‐NMR(75.4MHz,CDCl3):δ(ppm)173.2(C5),170.6(C2),137.5(C7),128.7(C9),128.5 (C8),125.6(C10),77.6(C3),68.8(C4),53.5(C1),20.8(C6).HRMS:m/zcalcd.forC12H14NaO5(M+Na+): 261.0373;found:261.0377. (±)‐Ethyl3‐acetoxy‐2‐(4‐cyanophenyl)‐2‐hydroxypropanoate,(±)‐3e:Colorlessoil(48.7mg,yield 88%).1H‐NMR(300MHz,CDCl3):δ(ppm)7.74–7.71(d,2H,J=8.6Hz,H10),7.62–7.59(d,2H,J=8.6 Hz,H9),4.61(d,1H,J=11.3Hz,H5),4.31–4.17(m,3H,H2andH5′),4.01(bs,1H,OH),2.00(s,3H,H7), 1.23(t,3H,J=7.1Hz,H1).13C‐NMR(75.4MHz,CDCl3):δ(ppm)171.7(C6),170.4(C3),141.0(C8),132.2 (C10),126.8(C9),119.0(C12),112.5(C11),77.3(C4),68.5(C5),63.5(C2),20.7(C7),14.0(C1).HRMS:m/z calcd.forC14H15NNaO5(M+Na+):300.0842;found:300.0849. Figure 2. Structure and NMR assignation of the synthesized racemic 1,2-diols (±)-2,3d and 6d. 3.3. General Synthesis of the Racemic Acetates (±)-1–6e To a solution of the corresponding racemic 1,2-diol ( ± )- 1 - 6d (0.2 mmol) in CH 2 Cl 2 (2.0 mL), pyridine (18 µ L, 0.22 mmol) and acetic anhydride (20 µ L, 0.22 mmol) were added at room temperature. The reaction was stirred until disappearance of the starting material (TLC using hexane/EtOAc 7:3 as the eluent). The crude reaction was washed with HCl 1.0 N (2 × 2.0 mL), dried with Na 2 SO 4 , and the solvent was removed under reduced pressure to yield the corresponding racemic acetates ( ± )- 1 – 6e , which were obtained after purification by column chromatography using n-hexane/EtOAc 7:3 as eluent (Figure 3). ( ± )-Ethyl 3-acetoxy-2-hydroxy-2-phenylpropanoate, ( ± )- 1e : Colorless oil (45.8 mg, yield 91%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.57–7.54 (m, 2H, H 10 ), 7.31–7.27 (m, 3H, H 9 and H 11 ), 4.68–4.64 (d, 1H, J= 11.3 Hz, H 5 ), 4.30–4.15 (m, 3H, H 2 and H 50 ), 3.84 (bs, 1H, OH), 2.00 (s, 3H, H 7 ), 1.22 (t, 3H, J= 7.1 Hz , H 1 ); 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 172.8 (C 6 ) 170.6 (C 3 ), 137.6 (C 8 ), 129.3 (C 10 ), 128.5 (C 9 ), 125.6 (C 11 ), 79.2 (C 4 ), 68.8 (C 2 ), 62.9 (C 5 ), 20.7 (C 7 ), 14.1 (C 1 ). HRMS: m/zcalcd. for C13H16NaO5(M + Na+): 275.0892; found: 275.0890. ( ± )-Methyl 3-acetoxy-2-hydroxy-2-phenylpropanoate, ( ± )- 2e : Colorless oil (44.2 mg, yield 93%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) δ (ppm) 7.55 (d, 2H, J= 8.2 Hz, H 9 ), 7.31–7.27 (m, 3H, H 8 and H 10 ), 4.64 (d, 1H, J= 11.2 Hz, H 4 ), 4.31 (d, 1H, J= 11.2 Hz, H 40 ), 3.77 (s, 3H, H 1 ), 2.54 (bs, 1H, OH), 2.01 (s, 3H, H 6 ). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 173.2 (C 5 ), 170.6 (C 2 ), 137.5 (C 7 ), 128.7 (C 9 ), 128.5 (C 8 ), 125.6 (C 10 ), 77.6 (C 3 ), 68.8 (C 4 ), 53.5 (C 1 ), 20.8 (C 6 ). HRMS: m/zcalcd. for C 12 H 14 NaO 5 (M + Na + ): 261.0373; found: 261.0377. ( ± )-Ethyl 3-acetoxy-2-(4-cyanophenyl)-2-hydroxypropanoate, ( ± )- 3e : Colorless oil (48.7 mg, yield 88%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.74–7.71 (d, 2H, J= 8.6 Hz, H 10 ), 7.62–7.59 (d, 2H, J= 8.6 Hz , H 9 ), 4.61 (d, 1H, J= 11.3 Hz, H 5 ), 4.31–4.17 (m, 3H, H 2 and H 50 ), 4.01 (bs, 1H, OH), 2.00 (s, 3H, H 7 ), 1.23 (t, 3H, J= 7.1 Hz, H 1 ). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 171.7 (C 6 ), 170.4 (C 3 ),
Molecules 2018,23, 1585 8 of 10 141.0 (C 8 ), 132.2 (C 10 ), 126.8 (C 9 ), 119.0 (C 12 ), 112.5 (C 11 ), 77.3 (C 4 ), 68.5 (C 5 ), 63.5 (C 2 ), 20.7 (C 7 ), 14.0 (C1).HRMS: m/zcalcd. for C14H15NNaO5(M + Na+): 300.0842; found: 300.0849. ( ± )-Ethyl 3-acetoxy-2-hydroxy-2-(4-methoxyphenyl)propanoate, ( ± )- 4e : Colorless oil (50.8 mg, yield 90%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.47 (d, 2H, J= 8.1 Hz, H 9 ), 6.91 (d, 2H, J= 8.1 Hz, H 10 ), 4.58 (d, 1H, J= 11.0 Hz, H 5 ), 4.30–4.15 (m, 3H, H 2 and H 50 ), 3.97 (bs, 1H, OH), 2.03 (s, 3H, H 7 ), 1.30 (t, 3H, J= 7.0 Hz, H 1 ). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 171.8 (C 6 ), 169.7 (C 3 ), 158.0 (C 11 ), 131.1 (C 8 ), 127.2 (C 9 ), 111.0 (C 10 ), 79.3 (C 4 ), 68.0 (C 5 ), 63.0 (C 2 ), 57.2 (C 12 ), 21.2 (C 7 ), 14.0 (C 1 ). HRMS: m/zcalcd. for C14H18O6(M+) 282.1103; found: 282.1098. ( ± )-Ethyl 3-acetoxy-2-hydroxy-2-(tiophen-2-yl)propanoate, ( ± )- 5e : Yellow pale oil (41.4 mg, yield 81%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.25 (dd, 1H, J= 5.1, 1.3 Hz, H 11 ), 7.10 (dd, 1H, J= 3.7, 1.3 Hz, H 10 ), 6.98 (dd, 1H, J= 5.1, 3.7 Hz, H 9 ), 4.56 (d, 1H, J= 11.1 Hz, H 5 ), 4.33–4.19 (m, 3H, H 2 and H 50 ), 2.91 (bs, 1H, OH), 2.00 (s, 3H, H 7 ), 1.25 (t, 3H, J= 7.0 Hz, H1). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 171.8 (C 6 ), 170.3 (C 3 ), 141.7 (C 8 ), 127.2 (C 11 ), 125.9 (C 10 ), 125.0 (C 9 ), 76.4 (C 4 ), 69.2 (C 5 ), 63.2 (C 2 ), 20.7 (C7), 13.9 (C1). HRMS: calcd. for C11H14NaO4S (M + Na+): 281.0456; found: 281.0454. ( ± )-Ethyl 2-(acetoxymethyl)-2-hydroxy-4-phenylbutanoate, ( ± )- 6e : Colorless oil (47.6 mg, yield 85%). 1 H-NMR (300 MHz, CDCl 3 ): δ (ppm) 7.21–7.18 (m, 2H, H 12 ), 7.13–7.07 (m, 3H, H 11 and H 13 ), 4.19–4.08 (m 4H, H 2 , H 5 and H 50 ), 3.51 (bs, 1H, OH), 2.79–2.70 (m, 1H, H 8 ), 2.45–2.35 (m, 1H, H 80 ), 1.99–1.90 (m, 5H, H 7 and H 9 ), 1.21 (t, 3H, J= 7.1 Hz, H 1 ). 13 C-NMR (75.4 MHz, CDCl 3 ): δ (ppm) 173.9 (C 6 ), 170.5 (C 3 ), 141.0 (C 10 ), 128.4 (C 11 ), 126.1 (C 12 ), 125.7 (C 13 ) , 76.0 (C 4 ), 68.9 (C 5 ), 62.4 (C 2 ), 36.8 (C 8 ), 29.3 (C 9 ), 20.7 (C7), 14.2 (C1). HRMS: m/zcalcd. for C15H20NaO5(M+): 303.1204; found: 303.1203. Molecules2018,23,xFORPEERREVIEW 8of10 (±)‐Ethyl3‐acetoxy‐2‐hydroxy‐2‐(4‐methoxyphenyl)propanoate,(±)‐4e:Colorlessoil(50.8mg,yield 90%).1H‐NMR(300MHz,CDCl3):δ(ppm)7.47(d,2H,J=8.1Hz,H9),6.91(d,2H,J=8.1Hz,H10), 4.58(d,1H,J=11.0Hz,H5),4.30–4.15(m,3H,H2andH5′),3.97(bs,1H,OH),2.03(s,3H,H7),1.30(t, 3H,J=7.0Hz,H1).13C‐NMR(75.4MHz,CDCl3):δ(ppm)171.8(C6),169.7(C3),158.0(C11),131.1(C8), 127.2(C9),111.0(C10),79.3(C4),68.0(C5),63.0(C2),57.2(C12),21.2(C7),14.0(C1).HRMS:m/zcalcd.for C14H18O6(M+)282.1103;found:282.1098. (±)‐Ethyl3‐acetoxy‐2‐hydroxy‐2‐(tiophen‐2‐yl)propanoate,(±)‐5e:Yellowpaleoil(41.4mg,yield 81%).1H‐NMR(300MHz,CDCl3):δ(ppm)7.25(dd,1H,J=5.1,1.3Hz,H11),7.10(dd,1H,J=3.7,1.3 Hz,H10),6.98(dd,1H,J=5.1,3.7Hz,H9),4.56(d,1H,J=11.1Hz,H5),4.33–4.19(m,3H,H2andH5′), 2.91(bs,1H,OH),2.00(s,3H,H7),1.25(t,3H,J=7.0Hz,H1).13C‐NMR(75.4MHz,CDCl3):δ(ppm) 171.8(C6),170.3(C3),141.7(C8),127.2(C11),125.9(C10),125.0(C9),76.4(C4),69.2(C5),63.2(C2),20.7 (C7),13.9(C1).HRMS:calcd.forC11H14NaO4S(M+Na+):281.0456;found:281.0454. (±)‐Ethyl2‐(acetoxymethyl)‐2‐hydroxy‐4‐phenylbutanoate,(±)‐6e:Colorlessoil(47.6mg,yield85%). 1H‐NMR(300MHz,CDCl3):δ(ppm)7.21–7.18(m,2H,H12),7.13–7.07(m,3H,H11andH13),4.19–4.08 (m4H,H2,H5andH5′),3.51(bs,1H,OH),2.79–2.70(m,1H,H8),2.45–2.35(m,1H,H8′),1.99–1.90(m, 5H,H7andH9),1.21(t,3H,J=7.1Hz,H1).13C‐NMR(75.4MHz,CDCl3):δ(ppm)173.9(C6),170.5(C3), 141.0(C10),128.4(C11),126.1(C12),125.7(C13),76.0(C4),68.9(C5),62.4(C2),36.8(C8),29.3(C9),20.7(C7), 14.2(C1).HRMS:m/zcalcd.forC15H20NaO5(M+):303.1204;found:303.1203. HO O O O 2 3 4 5,5' 8 9 9 10 10 11 O 1 67 HO O O O 1 2 3 4,4' 7 8 8 9 9 10 O 56HO O O O 2 3 4 5,5' 8 9 9 10 10 O 1 67 NC 11 12 HO O O O 2 3 4 5,5' 8 9 9 10 10 O 1 67 O11 12 HO O O O 2 3 4 5,5' 8 O 1 67 S 9 10 11 HO O O O 2 3 4 5,5' 8 9 11 10 O 1 67 12 11 12 13 (±)-1e (±)-2e (±)-3e (±)-4e (±)-5e (±)-6e Figure3.StructureandNMRassignationofthesynthesizedracemicacetates(±)‐1–6e. 3.4.GeneralProcedurefortheBiocatalyzedAcylationoftheRacemic1,2‐diols(±)‐1–6d Unlessotherwisestated,vinylacetate(0.9mmol)wasaddedtoasolutionoftheracemicdiol (±)‐1–6d(0.3mmol)inTBME(2.0mL)containingthePSL‐C(30mg)andNa2CO3(0.25mmol). Reactionswerestirredat30°Cat220rpmandmonitoredbyTLCusingn‐hexane/EtOAc7:3asthe eluent.Oncefinished,thelipasewasfiltered,washedwithTBME(2×2mL),andthesolventwas evaporatedunderreducedpressure.Thecrudemixturewaspurifiedbycolumnchromatography usingn‐hexane/EtOAc7:3astheeluentinordertoobtainthe(R)‐1,2‐diols1–6dandthe(S)‐acetates 1–6e,whichwereanalysedbyHPLCattheconditionsdescribedinTableS1forthedeterminationof theopticalpurities.(R)‐1d:37.8mg,60%yield;[α]21 D=−2.9(c=0.6,CHCl3,47%ee);(S)‐1e:23.0mg, 32%yield;[α]21 D=+10.8(c=1.0,CHCl3,92%ee).(R)‐2d:33.8mg,57%yield;[α]21 D=−3.8(c=0.5,CHCl3, 55%ee);(S)‐2e:24.1mg,35%yield;[α]21 D=+12.1(c=0.8,CHCl3,92%ee).(R)‐3d:50.5mg,71%yield; [α]21 D=−4.2(c=1.0,CHCl3,32%ee);(S)‐3e:19.4mg,22%yield;[α]21 D=+9.8(c=1.2,CHCl3,93%ee). (R)‐4d:51.6mg,72%yield;[α]21 D=−1.7(c=0.4,CHCl3,30%ee);(S)‐4e:16.9mg,20%yield;[α]21 D=+6.8 Figure 3. Structure and NMR assignation of the synthesized racemic acetates (±)-1–6e. 3.4. General Procedure for the Biocatalyzed Acylation of the Racemic 1,2-diols (±)-1–6d Unless otherwise stated, vinyl acetate (0.9 mmol) was added to a solution of the racemic diol ( ± )- 1 – 6d (0.3 mmol) in TBME (2.0 mL) containing the PSL-C (30 mg) and Na 2 CO 3 (0.25 mmol). Reactions were stirred at 30 ◦ C at 220 rpm and monitored by TLC using n-hexane/EtOAc 7:3 as the eluent. Once finished, the lipase was filtered, washed with TBME (2 × 2 mL), and the solvent was evaporated under reduced pressure. The crude mixture was purified by column chromatography using n-hexane/EtOAc 7:3 as the eluent in order to obtain the (R)-1,2-diols 1 – 6d and the (S)-acetates 1 – 6e , which were analysed by HPLC at the conditions described in Table S1 for the determination of the optical purities. (R)- 1d : 37.8 mg, 60% yield; [ α ] 21 D = − 2.9 (c= 0.6, CHCl 3 , 47% ee); (S)- 1e : 23.0 mg, 32% yield; [ α ] 21 D = +10.8 (c= 1.0, CHCl 3 , 92% ee). (R)- 2d : 33.8 mg, 57% yield; [ α ] 21 D = − 3.8 (c= 0.5, CHCl 3 , 55% ee); (S)- 2e : 24.1 mg, 35% yield; [ α ] 21 D = +12.1 (c= 0.8, CHCl 3 , 92% ee). (R)- 3d : 50.5 mg, 71%
Molecules 2018,23, 1585 9 of 10 yield; [ α ] 21 D = − 4.2 (c= 1.0, CHCl 3 , 32% ee); (S)- 3e : 19.4 mg, 22% yield; [ α ] 21 D = +9.8 (c= 1.2, CHCl 3 , 93% ee). (R)- 4d : 51.6 mg, 72% yield; [ α ] 21 D = − 1.7 (c= 0.4, CHCl 3 , 30% ee); (S)- 4e : 16.9 mg, 20% yield; [ α ] 21 D = +6.8 (c= 1.2, CHCl3, 92% ee). (R)-5d: 38.1 mg, 59% yield; [α]21 D=−2.7 (c= 0.75, CHCl3, 50% ee); (S)-5e: 23.2 mg, 30% yield; [ α ] 21 D = +10.2 (c= 1.05, CHCl 3 , 90% ee). (R)- 6d : 34.0 mg, 48% yield; [ α ] 21 D = − 3.8 (c= 0.5, CHCl3, 50% ee); and (S)-6e: 33.6 mg, 40% yield, [α]21 D= +5.6 (c= 1.2, CHCl3, 62% ee). 4. Conclusions A set of aromatic and non-aromatic 1,2-diols containing an ester moiety were prepared in a three-step procedure with moderate yields from the corresponding α -ketoesters. These functionalized racemic 1,2-diols were tested in lipase-catalysed acetylations. After optimization of the reaction conditions, we achieved good activities and selectivities in the resolution of aromatic 1,2-diols by employing the Pseudomonas cepacia lipase (PSL-C) in tert-butyl methyl ether as the solvent. This biocatalyst showed a higher selectivity for the preparation of chiral (R)-1,2-diols and (S)-acetates containing unsubstituted aromatic rings or presenting electron-withdrawing groups, whereas the reactions were slower and slightly less selective for aromatic substrates with electron-donating groups or heteroaromatic systems. PSL-C could be recycled for five reactions without appreciable loss in its biocatalytic properties, thus resulting in a promising biocatalyst for the preparation of optically active 1,2-diols. Supplementary Materials: The following are available online at http://www.mdpi.com/1420-3049/23/7/1585/ s1, Table S1: HPLC analyses; and assignment of 1H and 13C-NMR of synthesized compounds. Funding: This research received no external funding. Acknowledgments: This work was supported by the Ministerio de Economía y Competitividad, MINECO (contract RYC-2012-10014 for G.d.G., Grants CTQ2016-76908-C2-1-P and CTQ2016-76908-C2-2-P), the European FEDER Funds, and the Junta de Andalucía (Grant 2012/FQM 10787). Conflicts of Interest: Author declares no conflict of interest. References 1. Werner, L.; Machara, A.; Hudlicky, T. Short chemoenzymatic azide-free synthesis of oseltamivir (Tamiflu): Approaching the potential for process efficiency. Adv. Synth. Catal. 2010,352, 195–200. [CrossRef] 2. Wu, X.; Wang, L.; Wang, S.; Chen, Y. Stereoselective introduction of two chiral centers by a single diketoreductase: An efficient biocatalytic route for the synthesis of statin side chains. Amino Acids 2010 ,39, 305–308. [CrossRef] [PubMed] 3. Omori, A.T.; Finn, K.J.; Leisch, H.; Carroll, R.J.; Hudlicky, T. Chemoenzymatic total synthesis of (+)-codeine by sequential intramolecular Heck cyclizations via C-B-D ring construction. Synlett 2007,18, 2859–2862. 4. Kanicha, S.; Montgomery, J. Highly diastereoselective preparation of anti-1,2-diols by catalytic addition of alkynylsilanes to α-silyloxyaldehydes. Org. Lett. 2006,8, 4441–4443. 5. Bataille, C.J.R.; Donohoe, T.J. Osmium-free direct syn-dihydroxylation of alkenes. Chem. Soc. Rev. 2011 ,40, 114–128. [CrossRef] [PubMed] 6. Sharpless, K.B.; Akashi, K. Osmium catalyzed vicinal hydroxylation of olefins by tert-butyl hydroperoxide under alkaline conditions. J. Am. Chem. Soc. 1976,98, 1986–1987. [CrossRef] 7. Andersson, M.A.; Epple, R.; Fokin, V.V.; Sharpless, K.B. A new approach to osmium-catalyzed asymmetric dihydroxylation and aminohydroxylation of olefins. Angew. Chem. Int. Ed. 2002,41, 472–475. [CrossRef] 8. De Gonzalo, G.; Domínguez de María, P. Biocatalysis: An Industrial Perspective, 1st ed.; Royal Society of Chemistry: Cambridge, UK, 2017; ISBN 978-1-78262-619-0. 9. Sheldon, R.A.; Woodley, J.M. Role of biocatalysis in sustainable chemistry. Chem. Rev. 2018 ,118, 801–838. [CrossRef] [PubMed] 10. Patel, R.N. Green Biocatalysis, 1st ed.; John Wiley & Sons: Hoboken, NJ, USA, 2016; ISBN 978-1-118-82229-6. 11. Hudlicky, T.; Reed, J.W. Application of biotransformations and biocatalysis to complexity generation in organic synthesis. Chem. Soc. Rev. 2009,38, 3117–3132. [CrossRef] [PubMed]